Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 7/2019

Open Access 01-07-2019 | Care | Head & Neck

Non-curative treatment of patients with oral tongue squamous-cell carcinoma

Authors: R. Mroueh, A. Haapaniemi, T. Saarto, L. Grönholm, R. Grénman, T. Salo, A. A. Mäkitie

Published in: European Archives of Oto-Rhino-Laryngology | Issue 7/2019

Login to get access

Abstract

Purpose

Late-stage OTSCC is associated with poor overall survival (OS). Non-curative treatment approach aims to improve quality of life and prolong survival of patients deemed incurable. The purpose of this study was to investigate the used non-curative treatment modalities for OTSSC and patient survival.

Methods

All patients diagnosed with OTSCC and treated with non-curative intent at the HUS Helsinki University Hospital (Helsinki, Finland) during the 12-year period of 2005–2016 were included. Survival analysis after the non-curative treatment decision was conducted using the Kaplan–Meier method in this population-based study.

Results

Eighty-two patients were identified. A non-curative treatment decision was made at presentation without any previous treatment in 26 patients (7% of all patients diagnosed with OTSCC during the study period). Palliative radiotherapy was administered to 24% of all patients. The average survival time after the non-curative treatment decision was 3.7 months (median 2 and range 0–26).

Conclusions

Due to the short mean survival time after decision for treatment with non-curative intent, and the notable symptom burden in this patient population, a prompt initiation of all non-curative measures is warranted.
Literature
1.
2.
go back to reference Higginson IJ, Evans CJ (2010) What is the evidence that palliative care teams improve outcomes for cancer patients and their families? Cancer J 16:423–435CrossRefPubMed Higginson IJ, Evans CJ (2010) What is the evidence that palliative care teams improve outcomes for cancer patients and their families? Cancer J 16:423–435CrossRefPubMed
4.
go back to reference Cocks H, Ah-See K, Capel M, Taylor P (2016) Palliative and supportive care in head and neck cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol 130:S198–207CrossRefPubMedPubMedCentral Cocks H, Ah-See K, Capel M, Taylor P (2016) Palliative and supportive care in head and neck cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol 130:S198–207CrossRefPubMedPubMedCentral
5.
go back to reference Heinonen T, Loimu V, Saarilahti K, Saarto T, Makitie A (2018) End-of-life care pathway of head and neck cancer patients: single-institution experience. Eur Arch Otorhinolaryngol 275:545–551CrossRefPubMed Heinonen T, Loimu V, Saarilahti K, Saarto T, Makitie A (2018) End-of-life care pathway of head and neck cancer patients: single-institution experience. Eur Arch Otorhinolaryngol 275:545–551CrossRefPubMed
6.
go back to reference Mroueh R, Haapaniemi A, Grenman R, Laranne J, Pukkila M, Almangush A et al (2017) Improved outcomes with oral tongue squamous cell carcinoma in Finland. Head Neck 39:1306–1312CrossRefPubMed Mroueh R, Haapaniemi A, Grenman R, Laranne J, Pukkila M, Almangush A et al (2017) Improved outcomes with oral tongue squamous cell carcinoma in Finland. Head Neck 39:1306–1312CrossRefPubMed
7.
go back to reference Ferlay J, Soerjomataram I (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11. Lyon, France: International Agency for Research on Cancer. https://globocan.iarc.fr. Accessed 20 Dec 2018 Ferlay J, Soerjomataram I (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase no. 11. Lyon, France: International Agency for Research on Cancer. https://​globocan.​iarc.​fr. Accessed 20 Dec 2018
8.
go back to reference Hakulinen T, Tryggvadottir L, Gislum M, Storm HH, Bray F, Klint A et al (2010) Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 49:561–577CrossRefPubMed Hakulinen T, Tryggvadottir L, Gislum M, Storm HH, Bray F, Klint A et al (2010) Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 49:561–577CrossRefPubMed
9.
go back to reference Makitie AA, Koivunen P, Keski-Santti H, Tornwall J, Pukkila M, Laranne J et al (2007) Oral tongue carcinoma and its treatment in Finland. Eur Arch Otorhinolaryngol 264:263–267CrossRefPubMed Makitie AA, Koivunen P, Keski-Santti H, Tornwall J, Pukkila M, Laranne J et al (2007) Oral tongue carcinoma and its treatment in Finland. Eur Arch Otorhinolaryngol 264:263–267CrossRefPubMed
10.
go back to reference Ledeboer QC, van der Schroeff MP, Pruyn JF, de Boer MF, Baatenburg de Jong RJ, van der Velden LA (2011) Survival of patients with palliative head and neck cancer. Head Neck 33:1021–1026CrossRefPubMed Ledeboer QC, van der Schroeff MP, Pruyn JF, de Boer MF, Baatenburg de Jong RJ, van der Velden LA (2011) Survival of patients with palliative head and neck cancer. Head Neck 33:1021–1026CrossRefPubMed
11.
go back to reference Lok BH, Jiang G, Gutiontov S, Lanning RM, Sridhara S, Sherman EJ et al (2015) Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. Oral Oncol 51:957–962CrossRefPubMedPubMedCentral Lok BH, Jiang G, Gutiontov S, Lanning RM, Sridhara S, Sherman EJ et al (2015) Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. Oral Oncol 51:957–962CrossRefPubMedPubMedCentral
12.
go back to reference Shahid Iqbal M, Kelly C, Kovarik J, Goranov B, Shaikh G, Morgan D et al (2018) Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: a systematic review. Radiother Oncol 126:558–567CrossRefPubMed Shahid Iqbal M, Kelly C, Kovarik J, Goranov B, Shaikh G, Morgan D et al (2018) Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: a systematic review. Radiother Oncol 126:558–567CrossRefPubMed
13.
go back to reference Barker HE, Paget JTE, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15:409–425CrossRefPubMedPubMedCentral Barker HE, Paget JTE, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15:409–425CrossRefPubMedPubMedCentral
14.
go back to reference Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127CrossRef Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127CrossRef
15.
go back to reference Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695–1704CrossRef Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695–1704CrossRef
16.
17.
go back to reference da Silva SD, Hier M, Mlynarek A, Kowalski LP, Alaoui-Jamali MA (2012) Recurrent oral cancer: current and emerging therapeutic approaches. Front Pharmacol 3:149CrossRefPubMedPubMedCentral da Silva SD, Hier M, Mlynarek A, Kowalski LP, Alaoui-Jamali MA (2012) Recurrent oral cancer: current and emerging therapeutic approaches. Front Pharmacol 3:149CrossRefPubMedPubMedCentral
18.
go back to reference Caponigro F, Massa E, Manzione L, Rosati G, Biglietto M, De Lucia L et al (2001) Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG). Ann Oncol 12:199–202CrossRefPubMed Caponigro F, Massa E, Manzione L, Rosati G, Biglietto M, De Lucia L et al (2001) Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG). Ann Oncol 12:199–202CrossRefPubMed
19.
go back to reference Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE et al (2011) Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database Syst Rev (4):CD006386 Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE et al (2011) Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database Syst Rev (4):CD006386
20.
go back to reference Roland NJ, Bradley PJ (2014) The role of surgery in the palliation of head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 22:101–108CrossRefPubMed Roland NJ, Bradley PJ (2014) The role of surgery in the palliation of head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 22:101–108CrossRefPubMed
21.
go back to reference Schwam ZG, Husain Z, Judson BL (2015) Refusal of postoperative radiotherapy and its association with survival in head and neck cancer. Radiother Oncol 117:343–350CrossRefPubMed Schwam ZG, Husain Z, Judson BL (2015) Refusal of postoperative radiotherapy and its association with survival in head and neck cancer. Radiother Oncol 117:343–350CrossRefPubMed
22.
go back to reference Stavas MJ, Arneson KO, Ning MS, Attia AA, Phillips SE, Perkins SM et al (2015) The refusal of palliative radiation in metastatic non-small cell lung cancer and its prognostic implications. J Pain Symptom Manage 49:1081–1087CrossRefPubMed Stavas MJ, Arneson KO, Ning MS, Attia AA, Phillips SE, Perkins SM et al (2015) The refusal of palliative radiation in metastatic non-small cell lung cancer and its prognostic implications. J Pain Symptom Manage 49:1081–1087CrossRefPubMed
23.
go back to reference Osera S, Yano T, Odagaki T, Oono Y, Ikematsu H, Ohtsu A et al (2015) Peritonitis related to percutaneous endoscopic gastrostomy using the direct method for cancer patients. Surg Endosc 29:2941–2946CrossRefPubMed Osera S, Yano T, Odagaki T, Oono Y, Ikematsu H, Ohtsu A et al (2015) Peritonitis related to percutaneous endoscopic gastrostomy using the direct method for cancer patients. Surg Endosc 29:2941–2946CrossRefPubMed
24.
go back to reference Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT (2014) Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol 20:7739–7751CrossRefPubMedPubMedCentral Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT (2014) Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol 20:7739–7751CrossRefPubMedPubMedCentral
25.
go back to reference Madhoun MF, Blankenship MM, Blankenship DM, Krempl GA, Tierney WM (2011) Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? World J Gastroenterol 17:1004–1008CrossRefPubMedPubMedCentral Madhoun MF, Blankenship MM, Blankenship DM, Krempl GA, Tierney WM (2011) Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? World J Gastroenterol 17:1004–1008CrossRefPubMedPubMedCentral
26.
go back to reference Romesser PB, Romanyshyn JC, Schupak KD, Setton J, Riaz N, Wolden SL et al (2012) Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy. Cancer 118:6072–6078CrossRefPubMedPubMedCentral Romesser PB, Romanyshyn JC, Schupak KD, Setton J, Riaz N, Wolden SL et al (2012) Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy. Cancer 118:6072–6078CrossRefPubMedPubMedCentral
27.
go back to reference Kamisetty A, Mayland CR, Jack B, Lowe D, Rogers SN (2014) Place and time of death in patients treated with palliative intent for oral cancer. Br J Oral Maxillofac Surg 52:458–460CrossRefPubMed Kamisetty A, Mayland CR, Jack B, Lowe D, Rogers SN (2014) Place and time of death in patients treated with palliative intent for oral cancer. Br J Oral Maxillofac Surg 52:458–460CrossRefPubMed
28.
go back to reference Clark K (2017) Care at the very end-of-life: dying cancer patients and their chosen family’s needs. Cancers (Basel) 9:11CrossRef Clark K (2017) Care at the very end-of-life: dying cancer patients and their chosen family’s needs. Cancers (Basel) 9:11CrossRef
Metadata
Title
Non-curative treatment of patients with oral tongue squamous-cell carcinoma
Authors
R. Mroueh
A. Haapaniemi
T. Saarto
L. Grönholm
R. Grénman
T. Salo
A. A. Mäkitie
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 7/2019
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-019-05456-y

Other articles of this Issue 7/2019

European Archives of Oto-Rhino-Laryngology 7/2019 Go to the issue